• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Alkem Labs Q2FY25 Profit Rises 11%, Revenue Falls Marginally

    FINANCIALXPRESS

    CDSCO flags 49 medicine for failing quality; 4 declare as spurious

    ECONOMICTIMES

    Cipla, Alkem Laboratories in final lap to buy SMT

    ECONOMICTIMES

    PE firms queue up for Novartis` Indian arm

    ECONOMICTIMES

    Sonnet Bio Enters into Licensing Agreement with Alkem Laboratories

    GLOBENEWSWIRE

    Alkem Labs denies claims of Pan-D, Clavam 625 batches

    ECONOMICTIMES

    Alkem Lab`s Generics Ticagrelor Receives Tentative Approval in US

    FDA

    Alkem joins $3 bn race for JB Chem as Torrent pauses talks

    ECONOMICTIMES

    Alkem inks licensing pact with Takeda to introduce Vonoprazan in India

    ECONOMICTIMES

    Alkem`s Generics Riluzole Receives Approval in US

    FDA

    Alkem arm ties up with Exactech for knee, hip replacement implants

    ECONOMICTIMES

    Alkem Labs Generic Topiramate Receives Approval in US

    FDA

    Alkem Labs Generic Elagolix Receives Tentative Approval in US

    FDA

    Alkem Labs collaborates with 100 hospitals in tier-1 & tier-2 cities

    PHARMABIZ

    US FDA releases details of observations on Alkem`s Baddi Plant

    MONEYCONTROL

    FDA Issues form 483 to Alkem Laboratories Limited

    FDA

    Alkem Lab`s Generic Cefprozil Receives Approval in the U.S.

    FDA

    Alkem Laboratories sinks 3 percent on US FDA`s 10 observations for Himachal unit

    MONEY CONTROL

    SKCDA asks Alkem to recall anti-reflux drug PAN-D which are fake batch

    PHARMABIZ

    Alkem Lab`s Generic Mirabegro Receives Approval in the U.S.

    FDA

    Heritage Global Partners, New Mill Capital, Federal Equipment Company and Keith Machinery Corp Acquire Pharmaceutical Site from Alkem Laboratories

    BUSINESSWIRE

    Alkem completes sale of St. Louis manufacturing facility for US$ 7.96 million

    INDIAN PHARMA POST

    Alkem Lab`s Generic Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Receives Approval in the U.S.

    FDA

    USFDA inspection at Alkem Lab API manufacturing facility located at Mandva

    INDIAN PHARMA POST

    Alkem`s Generic Azilsartan Medoxomil, Chlorthalidone Receives Approval in the U.S.

    FDA

    Alkem Laboratories` Generic Brexpiprazole Receives Approval in the U.S.

    FDA

    Alkem ‘Healthy Lungs` initiative aims to clear the air

    INDIAN PHARMA POST

    Alkem rolls out patient awareness drive under its breathe initiative

    INDIAN PHARMA POST

    Alkem Laboratories` Generic Varenicline Tartrate Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of July 26, 2023

    FDA

    Alkem`s Generic Tapentadol Receives Approval in the U.S.

    FDA

    Alkem`s Generic (Topiramate) Receives Approval in the U.S.

    FDA

    Alkem Labs to grow chronic therapies, biosimilars to drive future growth: MD

    ECONOMIC TIMES

    Alkem`s Generic Dapagliflozin, Metformin HCL Receives Approval in the U.S.

    FDA

    ALKEM launches asthma awareness campaign #RelieverFreeIndia

    EXPRESS PHARMA

    Enforcement Report - Week of April 26, 2023

    FDA

    Enforcement Report - Week of April 5, 2023

    FDA

    Ascend Labs recalls anticoagulant pills on carcinogen concerns

    FIERCE PHARMA

    Alkem subsidiary Enzene launches adalimumab biosimilar in India

    ECONOMIC TIMES

    Enforcement Report - Week of February 22, 2023

    FDA

    Enforcement Report - Week of February 1, 2023

    FDA

    Alkem to launch novel antibiotic for MDR infections

    INDIAN PHARMA POST

    Alkem`s Generic Mirabegron Receives Approval in the U.S.

    FDA

    Jazz sues generics for infringement on cannabis-derived drug

    FIERCE PHARMA

    Alkem`s Generic Lurasidone Hydrochloride Receives Approval in the U.S.

    FDA

    Alkem`s Generic Eslicarbazepine Acetate Receives Approval in the U.S.

    FDA

    Alkem launches healthy lungs portal to spread awareness about paediatric asthma

    PHARMABIZ

    Alkem`s Generic Vancomycin Hydrochloride Receives Approval in the U.S.

    FDA

    USFDA issues Form-483 with 3 observations to Alkem Lab`s St Louis plant

    ECONOMIC TIMES

    AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others

    ENDPTS

    Alkem’s Fenton, Mo., Plant Slapped with 483 for Equipment, Process Control Issues

    FDA NEWS

    Alkem`s Generic Empagliflozin Receives Approval in the U.S.

    FDA

    Alkem and Stempeutics launch StemOne for treatment of knee osteoarthritis

    ECONOMIC TIMES

    Alkem`s Generic Tolvaptan Receives Approval in the U.S.

    FDA

    Alkem Laboratories’ net profit declined by 72.7% in Q1

    PHARMABIZ

    Alkem`s Generic Empagliflozin, Linagliptin Receives Approval in the U.S.

    FDA

    Alkem Lab Generic Diclofenac Potassium Receives Approval in the U.S.

    FDA

    Alkem Lab facility gets Form 483 with 3 observations from USFDA

    BUSINESS STANDARD

    Alkem Laboratories`s Generic Enalapril Maleate Receives Approval in the U.S.

    FDA

    Alkem Laboratories`s Generic Nifedipine Receives Approval in the U.S.

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.